DSS: Rapid Growth Across Diverse Business Segments
Investing - Small-Cap Market Intelligence • 9m 50s
Interview with COO of Document Security Systems (NYSE American: DSS). DSS is a multinational company operating businesses focused on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets. Its business model is based on a distribution sharing system in which shareholders will receive shares in its subsidiaries as DSS strategically spins them out into IPOs. Its historic business revolves around counterfeit deterrent and authentication technologies, smart packaging, and consumer product engagement. DSS is led by its seasoned leaders with decades of industry experience
Up Next in Investing - Small-Cap Market Intelligence
-
Lantern Pharma: AI-Based Drug Discove...
Lantern Pharma (NASDAQ: LTRN) is a clinical stage biotechnology company focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic data to transform the cost, risk and timeline of oncology drug discovery and development. Lantern utilizes its proprietary RADR® A.I. platfo...
-
Tiziana: Transforming Treatments for ...
Tiziana Life Sciences (NASDAQ: TLSA; LSE: TILS) is developing targeted therapeutics to transform treatment of liver diseases, inflammatory diseases, and cancer. Our clinical pipeline includes drug assets for Crohn's, and hepatocellular carcinoma. Tiziana’s two lead drug candidates, Foralumab and ...
-
Exclusive interview with Aptorum Grou...
Exclusive interview with Aptorum Group (NASDAQ: APM) President Darren Lui. Aptorum is a pharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs. Aptorum's current drug pipeline includes indications in orphan diseases, infectious diseases...
